CF
LABD icon

Cantor Fitzgerald’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Cantor Fitzgerald’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51,000
Closed -$831K – 344
2026
Q1 		$831K Buy
+51,000
New +$965K 0.01% 187

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Cantor Fitzgerald's LABD Position: Q2 2026 in Review

Cantor Fitzgerald sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026, closing a stake of 51,000 shares — an estimated $831K sold.

Cantor Fitzgerald first reported a position in LABD in Q1 2026 and held it in 1 quarter. The position peaked at $831K in Q1 2026. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • Cantor Fitzgerald reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2026 after selling out during the quarter.
  • Cantor Fitzgerald sold 51,000 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $831K.
  • Cantor Fitzgerald first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2026 and held it in 1 quarter.
  • Cantor Fitzgerald's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $831K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.